Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah
Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah
View: Text | PDF
Research Article Immunology

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is a central pathogenic process leading to aberrant production of type I interferon (IFN) in SLE, but the specific RNA molecules that serve as TLR7 ligands have not been defined. By leveraging gene expression data and the known sequence specificity of TLR7, we identified the female-specific X-inactive specific transcript (XIST) long noncoding RNA as a uniquely rich source of TLR7 ligands in SLE. XIST RNA stimulated IFN-α production by plasmacytoid DCs in a TLR7-dependent manner, and deletion of XIST diminished the ability of whole cellular RNA to activate TLR7. XIST levels were elevated in blood leukocytes from women with SLE compared with controls, correlated positively with disease activity and the IFN signature, and were enriched in extracellular vesicles released from dying cells in vitro. Importantly, XIST was not IFN inducible, suggesting that XIST is a driver, rather than a consequence, of IFN in SLE. Overall, our work elucidated a role for XIST RNA as a female sex–specific danger signal underlying the sex bias in SLE.

Authors

Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah

×

Figure 5

XIST activates IFN production in a cell-extrinsic, TLR7-dependent mechanism.

Options: View larger image (or click on image) Download as PowerPoint
XIST activates IFN production in a cell-extrinsic, TLR7-dependent mechan...
(A) Scatterplot showing average XIST expression in immune cells from 15 patients with lupus nephritis from the AMP data set versus IFN score (37). (B) Bar graphs showing XIST and IRF7 expression in response to IFN-α treatment as measured by qPCR in HEK293 cells, A431 cells, SLE patient PBMCs, and primary human keratinocytes. Upregulation of IRF7 versus XIST or IFI6 versus XIST compared by t test. *** indicates P < 0.001, and **** indicates P < 0.0001. (C and D) Bar graphs showing XIST expression fold-change calculated using the ΔΔCt method relative to GAPDH (C) or the relative quantity released (D) of XIST in EVs, calculated as the fold-change in XIST multiplied by the fold-change in the amount of RNA isolated, as measured by qPCR. Release of XIST RNA compared by t test. **** indicates P < 0.0001. (E) Our model for the role of XIST in SLE pathogenesis. (I) Dying cells release XIST and self-antigens. (II) XIST RNA activates TLR7 in pDCs. (III) Activated pDCs make large amounts of IFN, inducing the IFN signature and an inflammatory environment in the target tissue. (IV) Inflammatory environment and lymphocyte infiltration leads to increased cell death, inducing more XIST release to perpetuate the cycle. (B–D) Error bars represent 1 SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts